ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014

Cancer, AIDS Patient Advocates List Drug Development Concerns

May 12, 1989

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

RFA/PA/Drug Group Announcement Limited

May 6, 1988

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001